Buccal Drug Delivery Systems

References

• Pharmacology and the skin, R.J. Scheuplein, W. Montagna, R.B. Stoughton, E.J. Van Scott. Univ. of Chicago Press, Chicago, Illinois 1972; 36–37
   Google Scholar
• Tregear R.T. Physical functions of skin. Academic Press, London 1966
   Google Scholar
• Day T.D. J. Physiol. (London) 1952; 117: 1–8
   Google Scholar
• Gibaldi M., Kanig J.L. J. Oral. Ther. Pharmac 1965; 1: 440–450
   PubMedGoogle Scholar
• Tolo K.J. Arch. Oral. Biol. 1974; 19: 259–263
   PubMed Web of Science ®Google Scholar
• The epidermis, F.D. Malkinson, W. Montagna, W.C. Lobitz, Jr. Academic Press, New York and London 1964; 435–442
   Google Scholar
• Winkelmann R.K. Br. J. Derm. 1969; 81(Suppl. No.4)11–20
   PubMedGoogle Scholar
• Kaaber S. Acta. Odontol. Scand. 1974, Suppl no.66
   Google Scholar
• Squier C.A. Effect of Enzyme digestion on the permeability barrier in keratinizing and non-keratinizing epithelia. Br. J. Dermatol. 1984; 111: 253–264
   PubMed Web of Science ®Google Scholar
• Squier C.A., Johnson N.W. Brit. Med. Bull. 1975; 31: 169–175
   PubMed Web of Science ®Google Scholar
• Kurosaki Y., Takatori Toshihito, Nishimura Hidekatsu, Nakayama T., Kimura T. Regional Variation in oral mucosal drug absorption; Permeability and degree of keratinization in hamster oral cavity. Pharm. Res. 1991; 8: 1297–1301
   PubMed Web of Science ®Google Scholar
• Stratford R.E., Jr., Lee V.H.L. Amino peptidase activity in homogenates of various absorptive mucosae in the albino rabbit: implications in peptide delivery. Int. J. Pharm. 1986; 30: 73–82
   Web of Science ®Google Scholar
• Garren K.W., Repta A.J. Buccal drug absorption, comparitive levels of esterases and peptidase activity in rat and hamster buccal and intestinal homogenates. Int. J. Pharm. 1988; 48: 189–194
   Google Scholar
• Lysosomes: a laboratory handbook, W.T. Daems, E. Wissie, P. Brederoo, J.T. Dingle. North Holland, Amsterdam and London 1972; 150–199
   Google Scholar
• Wolff K., Schreiner E. Arch. Klin. Exp. Derm. 1969; 235: 203–220
   PubMedGoogle Scholar
• Squier C.A. J. Ultrastruct. Res. 1973; 43: 160–177
   PubMedGoogle Scholar
• Bernidge M.J., Oschman J.L. Transporting epithelia. Academic Press, New York & London 1972
   Google Scholar
• Pharmacology and the skin, W.W. Davis, W.E. Wright, W. Montagna, R.B. Stoughton, E.J. Van Scott. Appleton-Century-Crofts, New York 1972; 37–49
   Google Scholar
• Ussing H.H., Erlij D., Lassen U. Annu. Rev. Physiol. 1974; 36: 17–49
   PubMed Web of Science ®Google Scholar
• Seigel I.A., Hall S.H., Stambaugh R. Current concept of the Histology of oral mucosa. Thomas Springfeild, Illinois 1971; 274–286
   Google Scholar
• Barnett M.L., Szabo G.J. Periodontal Res. 1973; 8: 117–126
   Web of Science ®Google Scholar
• Tolo K.J. Arch. Oral. Biol. 1971; 16: 881–888
   PubMed Web of Science ®Google Scholar
• Pharmacology and the skin, J.H. Wills, W. Montagna, R.B. Stoughton, E.J. Van Scott. Appleton-Century-Crofts, New York 1972; 169–176
   Google Scholar
• Tolo K.J., Jonson B.J. Arch. Oral. Biol. 1975; 20
   PubMedGoogle Scholar
• Walton R.P. J. Am. Med. Assoc 1944; 124: 138–143
   Google Scholar
• Bickel M.H., Weder H.J. J. Pharm. PHarmacol. 1969; 21: 160–168
   PubMed Web of Science ®Google Scholar
• Beckett A.H., Moffat A.C. 1970; 22: 15–19, Ibid.
   Google Scholar
• Reza-Tavakoli M., Saberi M., Kenneth L. Audus. Physio-chemical factors affecting Beta-adrenargic antagonist permeation across cultured hamster pouch buccal epithelium. Int. J. Pharm. 1989; 56: 135–142
   Google Scholar
• Pharmacology and the skin, R.B. Stoughton, W. Montagna, E.J. Vanscott. Appleton-century-crofts, New York 1972; 535–546
   Google Scholar
• Tanaka Minako, Yangibashi Norio, Fukuda H., Nagai T. Absorption of salicylic acid through the oral mucous membrane of Hamster cheek pouch. Chem. Pharm. Bull. 1980; 28(4)1056–1061
   PubMed Web of Science ®Google Scholar
• Bremecker K.D. Modell Zur Bestimmung der Haftdauer Von Schleimhauthatsalben invitro. Pharm. Ind. 1983; 45: 417–419
   Web of Science ®Google Scholar
• Rhandhawa M.A., Blackett A.N., Turner. P. J.Pharm. Pharmacol. 1986; 38: 629–630
   Google Scholar
• Bartek M.J., Labuddle J.A., Maibach H.I. J. Invest. Derm. 1972; 58: 114–123
   PubMed Web of Science ®Google Scholar
• Walton R.P., Lacey C.F. J. Pharmacol. Exp.Ther. 1935; 54: 61–76
   Google Scholar
• Wallenius K. Acta. Pathol. Microbiol. Scand. 1966, Suppl. No. 1: 80
   Google Scholar
• Adams D. Arch. Oral Biol. 1974a; 19: 505–510
   PubMed Web of Science ®Google Scholar
• Michell M., Veillard, Longer M.A., Tucker I.G., Robinson J.R. Buccal controlled delivery of peptides. Proc. Int'l. symposium Control. Rel. Bio. Mat. 1987; 14: 22
   Google Scholar
• Rothman S. Physiology and Biochemistry of the skin. The Univeristy of Chicago Press, Chicago, Illinois 1954; 36–37
   Google Scholar
• Bruce J. Aungst, Nancy J. Rogers. Comparision of the effects of various transmucosal absorption promoters on buccal insulin delivery. Int. J. Pharm. 1989; 53: 227–235
   Google Scholar
• Moses A.C., Gordon G.S., Carey M.C., Flier J.S. Insulin administered intranasally as an insulin-bile salt aerosol: effectiveness and reproducibility in normal and diabetic subjects. Diabetes 1983; 32: 1040–1047
   PubMed Web of Science ®Google Scholar
• Pontiroli A.E., Alberelto M., Secchi A., Dossi G., Bosi I., Pozza G. Insulin given intranasally induces hypoglycemia in normal and diabetic subjects. Bit. Med. J. 1982; 284: 303–306
   PubMed Web of Science ®Google Scholar
• Yamasaki Y., Shichiri M., Kawamori R., Kikuchi M., Yagi T., Arai S., Tohdo R., Hakin N., Oji N., Abe H. The effectiveness of rectal administration of insulin suppository on normal and diabetic subjects. Diabetes Care 1981; 4: 454–458
   PubMed Web of Science ®Google Scholar
• Gibaldi M., Feldman S. Mechanism of surfactant effects on drug absorption. J. Pharm Sci. 1970; 59: 579–589
   PubMed Web of Science ®Google Scholar
• Attwood D., Florence AT. Biological applications of surfactant presence in formulation. Suractant Systems. Ed: Chapman & Hall, London 1983, Chapt. 7
   Google Scholar
• Seigel I.A., Gordon H.P. Toxicol. Lett. 1985; 26: 153–157
   PubMed Web of Science ®Google Scholar
• Seigel I.A., Gordon H.P. Arch. Oral. Biol. 1985; 30: 43–47
   PubMed Web of Science ®Google Scholar
• Kurosaki Y., Hisaichi S., Hamada C., Nakayama T., Kimura T. Effects of surfactants on the absorption of salicylic acid from hamster cheek pouch as a model of keratinized oral mucosa. Int. J. Pharm. 1988; 47: 13–19
   Web of Science ®Google Scholar
• Kurosaki Y., Hisaichi S., Hong Z.L., Nakayama T., Kimura T. Enhanced permeability of oral mucosa to salicylic acid with 1-dodecylazacycloheptan-2-one (Azone) In vitro studies in Hamster cheek pouch. Int. J. Pharm. 1989a; 49: 47–55
   Google Scholar
• Kurosaki Y., Hisaichi S., Nakayama T., Kimura T. Enhanceing effect of 1-dodecylazacycloheptan-2 -one (Azone) on the absorption of salicylic from keratinized oral mucosa and the duration of enhancement in vivo. Int. J. Pharm. 1989b; 51: 47–54
   Web of Science ®Google Scholar
• Berkovitz B.K., Holland G.R., Moxham B.J. A Colour Atlas & Text Book of oral Anatomy. Wolfe Medical, Holland 1978; 124–136
   Google Scholar
• Stoughton R.B., McClure W.O. Azone, a new non-toxic enhancer of cutaneous penetration. Drug. Dev. Ind. Pharm. 1983; 9: 725–744
   Web of Science ®Google Scholar
• Aungst B.J., Rogers N.J., Shefter E. Comparison of nasal, rectal, buccal, sublingual and intramuscular insulin efficacy and the effects of a bile salt absorption promoter. J. Pharmacol. Exp. Ther. 1988; 244: 23–27
   PubMed Web of Science ®Google Scholar
• Ishida Machida M.Y, Nambu N., Nagai T. New mucosal dosage forms of insulin. Chem. Pharm. Bull. 1981; 29: 810–816
   PubMed Web of Science ®Google Scholar
• Hirai S, Yashikki T., Mima H. Effect of surfactants on the nasal absorption of insulin in rats. Int. J. Pharm. 1981a; 9: 165–172
   Web of Science ®Google Scholar
• Ichikawa K., Ohata I, Mitomi M., Kawamura S., Maeno H., Kawata H. Rectal absorption of insulin suppositories in rats. J. Pharm. Pharmacol. 1980; 32: 314–318
   PubMed Web of Science ®Google Scholar
• Aungst B.J., Rogers N.J., Shefter E. Enhancement of nalaxone penetration through human skin in vitro using fatty acids, fatty alcohols, surfactants, sulfoxides and amides. Int. J. Pharm. 1986; 33: 225–234
   Web of Science ®Google Scholar
• Reeves D.S. The Pharmacokinetics of Fusidic Acid. J. Antimicrob. Chemother. 1987; 20: 467–476
   PubMed Web of Science ®Google Scholar
• Seaton T.A., Rogerson A., Parr G.D., Reckitt, Colman. Pharmaceuticals, Dansome Lane, Hull. HV8 &DS, UK, A novel in vitro model for assessment of buccal absorption of peptide drugs and the influence of penetration enhancers
   Google Scholar
• Jie Zhang, Suyi Niu, Lynn J. Maland, Bart K. Barrus, Volker R. Fremann, Brian I. Hague. Buccal Permeability of oral Transmucosal Fentanyl citrate in a dog model. Proceedings of an sympossium, Pharm. Res. 1991; 8(10)S-154
   Google Scholar
• Wang S.L., Jacober L, Chien Y.W., Slomiamy A., Slomiamy B.L. Int. J. Biochem. 1992; 24(1)
   Google Scholar
• Hopps R.M., Johnson N.W. J. Periodontal. Res. 1974; 9: 273–283
   PubMed Web of Science ®Google Scholar
• Mackenize I.C. Br. Dent. J. 1973; 134: 231–236
   PubMed Web of Science ®Google Scholar
• Symposium on Candida infections, R.A. Cawson, H.I. Winner, R. Hurley. Livingstone, Edinburgh 1972; 138–153
   Google Scholar
• Howlet J.A. J. Dent. Res. 1974; 53: 1076, (Abstract)
   Google Scholar
• Beckett A.H., Boyes R.N., Triggs E.J. J. Pharm. Pharmac. 1968; 20: 92–97
   PubMed Web of Science ®Google Scholar
• Beckett A.H., Moffat A.C. 1968; 20(Suppl.)239S–247S, Ibid.
   Google Scholar
• Beckett A.H., Moffat A.C. 1969a; 21(Suppl.)139S–143S, Ibid.
   Google Scholar
• Beckett A.H., Moffat A.C. 1969b; 21(Suppl.)144S–150S, Ibid.
   Google Scholar
• Schurmann W., Turner P. J. Pharm. Pharmacol. 1978; 30: 137–147
   PubMed Web of Science ®Google Scholar
• Ho N.F.H., Higuchi W.I. J. Pharm. Sci. 1971; 60: 537–541
   PubMed Web of Science ®Google Scholar
• Vora K.R.M., Higuchi W.I., Ho N.F.H. J. Pharm. Sci. 1972; 61: 1785–1791
   PubMed Web of Science ®Google Scholar
• Wagner J.G., Sedman A.J. J. Pharmacokinetics & Biopharmaceutics 1973; 1: 23–50
   Google Scholar
• Egelberg J. Acta. Odontol. Scand. 1963; 21(No.4)271–282
   PubMedGoogle Scholar
• Rizzo A.A. J. Periodontol. 1970; 41: 210–213
   PubMed Web of Science ®Google Scholar
• McDougall W.A. J. Periodontal Res. 1972; 7: 304–314
   PubMed Web of Science ®Google Scholar
• Bergman S., Siegel I.A., Ciancio S.J. Dent. Res. 1968; 47: 1184
   PubMed Web of Science ®Google Scholar
• Schilli W., Hamann W., Adrain I., Ochlert W. Arch., Oral, Biol. 1967; 12: 701–712
   PubMed Web of Science ®Google Scholar
• Salley J.J. J. Dent. Res. 1961; 40: 177–184
   PubMed Web of Science ®Google Scholar
• Weinstein E., Mandel I.D., Salkind A., Oshrain H.I., Pappas G.D. Periodontics 1967; 5: 161–166
   Google Scholar
• Gavin J.B. J.Periodont. Res. 1969, Suppl. No. 4: 20–21
   Google Scholar
• McDougall W.A. Arch Oral. Biol. 1970; 15: 621–633
   PubMed Web of Science ®Google Scholar
• McDougall W.A. J. Periodontal Res. 1971; 6: 89–99
   PubMedGoogle Scholar
• Squier C.A., Rooney L. J. Dent. Res. 1974; 53: 1071, (Abstract)
   Google Scholar
• Beckett A.H., Triggs E.J. 1967; 19(Suppl.)31S–41S, Ibid.
   Google Scholar
• Phrm., Res. 1991; 8(10)S-157, Renu Gambhir & Stanford Bolton, St. John's University, Jamaica NY, 11436, Glaxo Canada Inc. Toranto, ONT M8Z 5S6, through Proc. Int'l.symposium report in
   Google Scholar
• Adams D. Arch. Oral Biol. 1974b; 19: 865–872
   PubMed Web of Science ®Google Scholar
• Galey W.R., et al. J. Invest. Dermatol. 1976; 67: 713–717
   PubMed Web of Science ®Google Scholar
• Quadros E., Cassidy J., Tipnis V., Livingston T., Laugley S. Pharm., Res. 1991; 8(10)S-157, Ciba-Geigy Corporation, Ardsley, NY 10502 and Medival,Manchester, U.K. through, Proc. Int'l. symposium report in
   Google Scholar
• Nagai T., Konishi R. Buccal/Gingival drug delivery system. Proc. 3rd Int'l. Symposium on Recent Advances in Drug delivery systems, Salt Lake City UTUSA, 1987; 353–360
   Google Scholar
• Smart J.D., Kellaway I.W., Worthington H.E.C. An in vitro investigation of mucosa-adhesive materials for use in controlled drug delivery. J. Pharm. Pharmacol. 1984; 36: 295–299
   PubMed Web of Science ®Google Scholar
• Reinhold Anders, Hans P. Merkle. Evaluation of a laminated muco-adhesive patches for buccal drug delivery. Int. J. Pharm. 1989; 49: 231–240
   Google Scholar
• Davis S.S., Daly P.B., Kennerley J.W., Frier M., Hardy J.G., Wilson C.G. Design and evaluation of sustained release formulation for oral and buccal administration. Controlled release invitro glycerine in buccal and oral form, W.D. Bussmann, R.R. Dries, W. Wagner. Karger, Basle 1982; 17–25
   Google Scholar
• Schor J.M., Davis S.S., Nigalaye A., Bolton S. Susadrin Transmucosal tablets. Drug Dev. Ind. Pharm. 1983; 9: 1359–1377
   Web of Science ®Google Scholar
• Ishida Nambu M., Nagai T. Chem. Pharm. Bull. 1983; 31: 4561–4564
   PubMed Web of Science ®Google Scholar
• Ishida Machida M.Y., Nambu N, Nagai T. Chem. Pharm. Bull. 1982; 30: 980–984
   PubMed Web of Science ®Google Scholar
• Bremecker K.D., Strempel H., Klein G., Rubesamen-Vokul A. Formulating and kolinische Eropoobung einer neuartigen Schleimhauthaftsalbe. Arzeneim-Forsch/Drug Res. 1983; 33: 591–594
   PubMedGoogle Scholar
• Anders R. Selbsthaftende polymerfilme zur bukkalen Applikation Von Peptiden. Universtat Bonn. 1984, (Ph.D. Thesis)
   Google Scholar
• Bremecker K.D., Strempel H., Klein G. Novel concept for Mucosal-adhesive Ointment. J. Pharm. Sci., 73
   PubMed Web of Science ®Google Scholar
• Merkle H.P., Anders R., Sandoro J., Schurr W. Drug delivery of peptides: the buccal route. Delivery system for peptide drugs. NATO ASI series, Series A: Life Sciences, S.S. Davis, L Ilium, E. Tomlinson. Plenum, New York 1986; Vol. 125: 159–175
   Google Scholar
• Jonsonn V.E. Various administration forms of nitrates and possibilities. Drugs 1987; 33(Suppl. 4)23–31
   PubMedGoogle Scholar
• Asthana O.P., Woodcock B.G., Wenchel M., Fronching K.H., Reitbrock N. Arzneimittel Forschung 1984; 34: 498–502
   PubMed Web of Science ®Google Scholar
• Housten M.C. Treat ment of hypertensive urgencies and emergencies with nifedipine. American Heart Journal 1986; 111: 963–969
   PubMed Web of Science ®Google Scholar
• Fisher B.V., Smith D. HPLC as a replacement for the animal response assays for insulin. J. Pharm. Biomed. Anal. 1986; 4: 377–387
   PubMed Web of Science ®Google Scholar
• Russel M.A.H., Jarius M.J. Theorotical background and clinical use of nicotine chewing gum. Pharmacological Adjuvants in smoking cessation, J. Grabowski, S.M. Hall. U.S. Government Printing Office, Washington, DC 1985
   Google Scholar
• Brook I.M., Tucker G.T., Tuckley E.C., Boyes R.N. A lignocaine patch for dental analgesia safety and early pharmacology. J. control. Res. 1989; 10: 183–188
   Web of Science ®Google Scholar
• Boyes R.N. Information on file. Invovata Biomed, Ltd., St Albans 1984; 548, Herts. AL3 4ES, Great Britain
   Google Scholar
• Schurr W., Zeigler R. Buccal absorption of protirelin: An effective way to stimulate Thyrotropin and prolactin. J. Pharm. Sci. 1983; 72: 1481–1483
   PubMed Web of Science ®Google Scholar
• Hussain A.M., Aungst J.B., Shefter E. Buccal and Oral Bioavailability of Nalbupine in rats. J. Pharm.Sci. 1986; 75: 218–219
   PubMed Web of Science ®Google Scholar